QUBT Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
Not a good buy right now for an impatient trader. QUBT is in a clear short-term downtrend (bearish MA stack, negative/expanding MACD), and there are no Intellectia buy signals today to justify stepping in early. Options positioning is mildly bullish (calls outweigh puts), but price action is still weak and the stock is sitting just above the next key support zone (~9.25). Best stance here is HOLD/AVOID new buys until the trend turns or a proprietary buy signal appears.
Trend/structure: Bearish. Moving averages are stacked down (SMA_200 > SMA_20 > SMA_5), confirming a sustained downtrend. Momentum: MACD histogram is negative (-0.183) and expanding lower, which typically signals downside momentum is still building. RSI: RSI(6) at ~26 is deeply oversold (despite the label), which can produce sharp bounces, but oversold alone is not a reliable buy trigger while MACD/MA trend remain bearish. Levels: Current price 9.9 is below S1 (10.075) and above S2 (9.252). That places the stock in a fragile zone—any further weakness risks a support test near ~9.25; upside reclaim would first need to retake ~10.08 and then pivot ~11.41. Pattern-based short horizon odds: Similar-pattern stats suggest ~-0.49% next day and ~-1.11% next week bias, with a stronger +25.22% 1-month skew (high volatility swing potential).
Intellectia Proprietary Trading Signals
on 2026-02-12 after hours could re-price the stock quickly if guidance surprises.
Technical downtrend remains dominant (bearish MAs + weakening MACD), increasing the probability of further downside before any durable rebound.
Industry/stock volatility: Quantum peers have shown extreme boom-bust behavior; multiple articles highlight that rapid sector gains may be unsustainable at this early commercialization stage.
Business scale: Company still lacks meaningful, consistent revenue per analyst commentary; execution risk remains high.
Near-term risk into earnings: Next earnings are upcoming (2026-02-12 AH) with an EPS estimate around -0.04, which can trigger sharp downside if growth/guidance disappoints.
Latest reported quarter: 2025/Q3. Revenue: $384K (+280.20% YoY) — strong growth rate, but from a very small base. Profitability: Net income fell to $2.382M (-141.97% YoY) and EPS was $0.01 (-116.67% YoY), indicating earnings quality/consistency is weak. Margins: Gross margin improved to ~32.81% (+268.24% YoY), a positive sign for unit economics, but overall scale remains the key issue.
Recent trend: Mixed-to-cautious but still with upside targets.
